AmerisourceBergen Corporation – Consensus Indicates Potential 14.7% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 191 and 150 with the average target price sitting at 171.92. Given that the stocks previous close was at 149.91 this would indicate that there is a potential upside of 14.7%. The 50 day moving average now sits at 143.86 and the 200 moving average now moves to 141.97. The company has a market capitalisation of $31,509m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,136m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 14.7% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 191 and 150 with the average target price sitting at 171.92. Given that the stocks previous close was at 149.91 this would indicate that there is a potential upside of 14.7%. The 50 day moving average now sits at 143.86 and the 200 moving average now moves to 141.97. The company has a market capitalisation of $31,509m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,136m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.